Sun Pharma open to exploring acquisitions in global specialty portfolio | Company News
3 min read Last Updated : Jul 08 2024 | 10:12 PM IST The country’s largest drugmaker by market share Sun Pharmaceutical Industries says it is open to exploring acquisitions in the global specialty portfolio as it closed financial year 2023-24 (FY24) with a strong net cash position of $2.4 billion. In the 2023-24 annual…